A8新媒體(00800.HK)斥1,000萬人幣投資青松基金IV
A8新媒體(00800.HK)公布,通過其間接全資附屬公司快通聯與前海青松及三個其他投資者計劃設立青松基金IV,以主要針對新科技及應用和新消費等新型產業領域進行股權投資。
快通聯、前海青松及其他投資者就有關設立及投資青松基金IV訂立合夥協議。根據合夥協議,集團將以有限合夥人身份投資1,000萬元人民幣(大約相當於1,120萬港元)認購青松基金IV約11.111111%的權益。
青松基金IV的設立需經深圳市市場監督管理局批准。青松基金IV將以有限合夥形式在中國成立,主要從事風險投資,風險投資管理以及與風險投資有關的其他活動,以促進新興產業的發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.